Sangamo Therapeutics, Inc. SGMO Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sangamo Therapeutics, Inc. SGMO

SGMO 0.590

+3.6%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: investingNideas	8/12/2010 4:01:13 PM
	Read Replies (1) of 368

sigma-aldrich-corporation-q2-2010 "As we have reported in the past, we are very excited about the potential of the zinc finger technology and its ability to enable us to be a key player in the life science space. We have another first here. We recently introduced the world’s first B53 knockout rack model, an important development that is expected to significantly improve timelines for carcinogenicity screening and improve the time to market for therapeutics." seekingalpha.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next